Kronos Bio, Inc. (KRON)
NASDAQ: KRON · IEX Real-Time Price · USD
1.170
+0.050 (4.46%)
At close: Jul 2, 2024, 4:00 PM
1.160
-0.010 (-0.85%)
After-hours: Jul 2, 2024, 5:36 PM EDT
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $70.31 million as of July 2, 2024. Its market cap has decreased by -21.79% in one year.
Market Cap
70.31M
Enterprise Value
-56.23M
1-Year Change
-21.79%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $70.31M, a decrease of -92.98%. That is a compound annual growth rate of -50.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 70.30M | -3.57% |
Dec 29, 2023 | 72.90M | -20.93% |
Dec 30, 2022 | 92.20M | -87.96% |
Dec 31, 2021 | 765.80M | -54.25% |
Dec 31, 2020 | 1.67B | 67.00% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Checkpoint Therapeutics | 75.92M |
Oncolytics Biotech | 75.09M |
FibroGen | 74.66M |
IO Biotech | 74.45M |
Cognition Therapeutics | 72.91M |
Serina Therapeutics | 72.36M |
Benitec Biopharma | 72.32M |
SCYNEXIS | 72.16M |